ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
102 289,49
-0,12%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) Actualités

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateHeureSourceTitreSymboleSociété
30/01/202522h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
30/01/202511h45PR Newswire (US)Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:CRBUCaribou Biosciences Inc
27/01/202511h45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
23/01/202511h45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) ShareholdersNASDAQ:CRBUCaribou Biosciences Inc
20/01/202511h45PR Newswire (US)Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBUNASDAQ:CRBUCaribou Biosciences Inc
16/01/202511h45PR Newswire (US)CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
13/01/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
13/01/202511h45PR Newswire (US)Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUNASDAQ:CRBUCaribou Biosciences Inc
13/01/202501h05GlobeNewswire Inc.Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025NASDAQ:CRBUCaribou Biosciences Inc
10/01/202522h55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202511h45PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
07/01/202522h00GlobeNewswire Inc.Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CRBUCaribou Biosciences Inc
06/01/202511h45PR Newswire (US)The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUNASDAQ:CRBUCaribou Biosciences Inc
02/01/202514h00GlobeNewswire Inc.Caribou Biosciences Appoints Sri Ryali as Chief Financial OfficerNASDAQ:CRBUCaribou Biosciences Inc
06/12/202422h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
20/11/202422h00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
15/11/202400h08Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202422h05GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
27/09/202422h02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
25/09/202415h00GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024NASDAQ:CRBUCaribou Biosciences Inc
03/09/202414h00GlobeNewswire Inc.Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AMLNASDAQ:CRBUCaribou Biosciences Inc
12/08/202414h00GlobeNewswire Inc.Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical OfficerNASDAQ:CRBUCaribou Biosciences Inc
06/08/202422h05GlobeNewswire Inc.Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
09/07/202414h00GlobeNewswire Inc.Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory BoardNASDAQ:CRBUCaribou Biosciences Inc
03/06/202401h00GlobeNewswire Inc.Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
30/05/202422h01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
07/05/202422h05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
24/04/202416h00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
15/04/202415h00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Dernières Valeurs Consultées

TG
A3LT2D
HYPO NOE Landesbank for ...
LSE
0OCP
USOTC
MINM
Minim (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces